AIMEE FOORD
Allopathic & Osteopathic Physicians|Pediatrics|Pediatric Hematology-Oncology LAS VEGAS, NV NPI 1821312844
Browse related groups: Allopathic & Osteopathic Physicians|Pediatrics|Pediatric Hematology-Oncology NV GENZYME CORPORATION All categories
General Payments — all program years on this page
$16,881.22
- Category: General Payments
- Program years: PY2022–2024
- Record count: 52
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $15,261.95 across 28 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $11,533.00 | 3 |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $2,400.00 | 1 |
| Food and Beverage | $885.67 | 21 |
| Travel and Lodging | $443.28 | 3 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| GENZYME CORPORATION | $7,657.47 | 5 |
| HEMA Biologics, LLC | $3,025.00 | 1 |
| PFIZER INC. | $2,648.46 | 6 |
| SOBI, INC | $1,484.14 | 3 |
| Pharming Healthcare, Inc. | $121.81 | 1 |
| Novo Nordisk AS | $40.35 | 2 |
| JAZZ PHARMACEUTICALS INC. | $39.09 | 1 |
| CHIESI USA, INC. | $36.91 | 1 |
| Pharmacosmos Therapeutics Inc. | $34.86 | 1 |
| Adaptive Biotechnologies Corporation | $33.97 | 1 |
| Octapharma USA, Inc. | $28.62 | 1 |
| SERVIER PHARMACEUTICALS LLC | $24.71 | 1 |
| Apellis Pharmaceuticals, Inc. | $23.95 | 1 |
| Genentech USA, Inc. | $23.83 | 1 |
| Kedrion Biopharma, Inc. | $19.60 | 1 |
| RARE DISEASE THERAPEUTICS, INC. | $19.18 | 1 |
By program year
Records — PY2024 (28)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.